HR 4134
118th Congress
House
Health
Administrative law and regulatory procedures
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Prescription drugs
Updated Drug Labeling for Patient Safety Act
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 16, 2023
Referred to the Subcommittee on Health.
Jun 14, 2023
Referred to the House Committee on Energy and Commerce.
Jun 14, 2023
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Updated Drug Labeling for Patient Safety Act
This bill allows generic drug manufacturers to revise labels with updated safety information that differs from the referenced brand-name drug.
What's happening now
Referred to the Subcommittee on Health.
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
2
Cosponsors
3
Cite this page
U.S. Congress. (2026). H.R. 4134: Updated Drug Labeling for Patient Safety Act. 118th Congress. Open America. https://openamerica.io/bill/118-HR-4134/
"H.R. 4134: Updated Drug Labeling for Patient Safety Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-4134/.
H.R. 4134, 118th Cong. (2026), https://openamerica.io/bill/118-HR-4134/.
[H.R. 4134: Updated Drug Labeling for Patient Safety Act](https://openamerica.io/bill/118-HR-4134/)